Health News from WN Network

Friday, 11 April 2014

Doctors welcome hepatitis C drug rivals, Gilead still leads

LOS ANGELES/LONDON (Reuters) - Doctors at a key medical conference welcomed the prospect of more new drugs to treat the liver-destroying hepatitis C virus, while agreeing that Gilead Sciences Inc continues to lead the effort. Gilead, under fire from insurers and legislators for the $1,000-a-pill price of its Sovaldi drug, presented pivotal data on Friday at the European Association for the Study of the Liver conference in London, showing a cure rate of 94 percent after eight weeks of treatment...

Full Story: Reuters

More Health News Stories

1st female physician in US House speaks on health Sacramento Bee

COLUMBIA, S.C. -- The first female physician to serve in the U.S. House of Representatives is speaking at the Columbia...

Nebraskan pleads not guilty in suicide case Sacramento Bee

SIDNEY, Neb. -- A western Nebraska woman has pleaded not guilty to charges that she helped her husband kill...

Huntington Ingalls Industries to Explore Opportunities for Avondale Redevelopment With Kinder Morgan Energy Partners (Huntington Ingalls Industries Inc) noodls

(Source: Huntington Ingalls Industries Inc) Huntington Ingalls Industries to Explore Opportunities for Avondale Redevelopment With Kinder Morgan Energy Partners NEWPORT NEWS, Va., April 11, 2014 (GLOBE NEWSWIRE) -- Huntington Ingalls Industries (NYSE:HII) announced today it will conduct a study with...

11 April 2014 - UK-wide report shows Northern Ireland’s health system has made significant improvements: Poots (Northern Ireland Executive) noodls

(Source: Northern Ireland Executive) Health Minister Edwin Poots today said a major new report comparing healthcare systems across the United Kingdom's four devolved governments demonstrates that Health and Social Care (HSC) in Northern Ireland has made significant improvements. ~ Friday, 11...

United States Food and Drug Administration Grants an Investigational Device Exemption for Compassionate Use of ReCell (Avita Medical Ltd) noodls

(Source: Avita Medical Ltd) United States Food and Drug Administration Grants an Investigational Device Exemption for Compassionate Use of ReCell Highlights The IDE granted by the US FDA allows ReCell to be evaluated clinically as an investigational device in subjects with life-threatening...

Emergency communications book developed in Surrey wins Red Cross Excellence Award (British Red Cross) noodls

(Source: British Red Cross) 11 April 2014 For immediate release Friday 11 April 2014 For further information Rebecca McIlhone rmcilhone@redcross.org.uk Contact number 0117 3012624 07525 128297 A picture-based resource designed to improve communications with disabled people during...

Transformation of health and social care services on agenda for Health and Wellbeing Board (West Sussex County Council) noodls

(Source: West Sussex County Council) Date: 11 April 2014 Press release number: PR5916 The implementation of plans to transform local health and social care services are on the agenda for the next meeting of the West Sussex Health and Wellbeing Board. The Board will be looking at how these plans,...

Discovery of a mechanism that turns tumour cells into sugar ‘addicts’ (Universitat de Barcelona) noodls

(Source: Universitat de Barcelona) 11/04/2014 Recerca Nearly a hundred years ago, research demonstrated that cancer cells feel a special appetite for a type of sugar called glucose. Tumour use glucose like a sports car uses gasoline: it depends on it to burn faster, to grow and to multiply rapidly....

Diseases